|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
ViroStatics CEO Franco Lori, MD to Present Novel Immune-based Technologies for HIV/AIDS and Chronic Diseases at the 2011 Biotechnology Industry Organization (BIO) International Conference
6/27/2011 10:02:38 AM
SASSARI, Italy & PRINCETON, N.J.--(BUSINESS WIRE)--ViroStatics, an Italian/American biopharmaceutical company developing novel therapeutics for viral and other chronic diseases, announced today that the Company’s CEO, Franco Lori, MD, will be an invited speaker at the 2011 BIO International Convention being held this week in Washington, DC. Dr. Lori will participate in a panel discussion entitled "Looking to the Future: Innovative Approaches to HIV Vaccine Development and Immunotherapies" that will take place on Wednesday, June 29th at 10:00 am in Room 151B in the Walter E. Washington Convention Center.
|
|
|
|
|
|
|
|
|
|
|